The Assistance Fund (TAF) Sickle Cell Disease Financial Assistance Program

The Assistance Fund's Sickle Cell Disease Financial Assistance Program offers grants for ground travel costs to a treatment center for FDA-approved treatments, as well as other out-of-pocket medical expenses. Eligible patients must be U.S. citizens or permanent residents diagnosed with Sickle Cell Disease, have prescription coverage, and meet financial eligibility criteria based on household income and size. The program is currently on a waitlist.